Aytu BioPharma, Inc (AYTU) stock
AYTUNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3070% below fair value
$2.66+0.00 (0.00%)
Close on Nov 20, 2026Market cap $28.91MP/E –Yield –
Aytu BioPharma free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Aytu BioPharma's free cash flow for the twelve months ending Jun 30, 2026 was $3.25M. For fiscal 2026 it was $3.25M. The highest annual figure on record is $3.25M in fiscal 2026.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $3.25M | – |
| FY2025 | Jun 30, 2025 | -$2.17M | – |
| FY2024 | Jun 30, 2024 | -$1.72M | – |
| FY2022 | Jun 30, 2022 | -$28.82M | – |
| FY2021 | Jun 30, 2021 | -$28.31M | – |
| FY2020 | Jun 30, 2020 | -$28.37M | – |
| FY2019 | Jun 30, 2019 | -$13.89M | – |
| FY2018 | Jun 30, 2018 | -$16.02M | – |
| FY2017 | Jun 30, 2017 | -$13.94M | – |
| FY2016 | Jun 30, 2016 | -$10.91M | – |
| FY2015 | Jun 30, 2015 | -$6.63M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $4.39M | +57.7% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$4.18M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $3.66M | +26.2% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$618.00K | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $2.79M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$6.52M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $2.90M | -57.2% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$1.33M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$1.12M | -105.8% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$254.00K | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $6.78M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$1.91M | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $19.25M | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$10.60M | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$2.99M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | -$3.47M | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | -$3.36M | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -$4.31M | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -$2.75M | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | -$4.54M | – |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | -$4.14M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -$3.33M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$2.40M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$2.88M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$5.34M | – |
See a number that looks wrong?